Catalyst Wire Dossier Catalyst Wire Dossier

FS-67

· Hisamitsu Pharmaceutical Co., Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FS-67, covering 2022-10-06 to 2022-10-06. Get the full timeline:

Most recent: Clinical Trial Update: FS-67 in the Treatment of Pediatric Patients With Ankle Sprain [Phase 4]

See pricing